Hypersensitivity reactions related to oxaliplatin (OHP)

por Brandi, G, Pantaleo, M A, Galli, C, Falcone, A, Antonuzzo, A, Mordenti, P, Di Marco, M C, Biasco, G
Publicado 2003

Phase II study of sequential chemotherapy with docetaxel–estramustine followed by mitoxantrone–prednisone in patients with advanced hormone-refractory prostate cancer

por Galli, L, Fontana, A, Galli, C, Landi, L, Fontana, E, Antonuzzo, A, Andreuccetti, M, Aitini, E, Barbieri, R, Di Marsico, R, Falcone, A
Publicado 2007

First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II...

por Tibaldi, C, Vasile, E, Antonuzzo, A, Di Marsico, R, Fabbri, A, Innocenti, F, Tartarelli, G, Amoroso, D, Andreuccetti, M, Dico, M Lo, Falcone, A
Publicado 2008

A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer

por Vasile, E, Masi, G, Fornaro, L, Cupini, S, Loupakis, F, Bursi, S, Petrini, I, Di Donato, S, Brunetti, I M, Ricci, S, Antonuzzo, A, Chiara, S, Amoroso, D, Andreuccetti, M, Falcone, A
Publicado 2009

1711P SARS-CoV-2 infection in prostate cancer patients: Data from a high-incidence area in Italy

por Sbrana, A., Paolieri, F., Bloise, F., Nuzzo, A., Manacorda, S., Sammarco, E., Manfredi, F., Mercinelli, C., Gadducci, G., Giannini, N., Antonuzzo, A., Paiar, F., Falcone, A., Pasqualetti, F., Galli, L.
Publicado 2020

Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by...

por Rossini, D., Boccaccino, A., Sbrana, A., Daniel, F., Borelli, B., Raimondi, A., Santini, D., Conca, V., Tomasello, G., Caponnetto, S., Marmorino, F., Zaniboni, A., Buonadonna, A., Masi, G., Lonardi, S., Pietrantonio, F., Falcone, A., Antonuzzo, A., Cremolini, C.
Publicado 2021